EMAIL THIS PAGE TO A FRIEND

Journal of virology

A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection.


PMID 25210171

Abstract

Streptococcus pneumoniae is a major causative pathogen in community-acquired pneumonia; together with influenza virus, it represents an important public health burden. Although vaccination is the most effective prophylaxis against these infectious agents, no single vaccine simultaneously provides protective immunity against both S. pneumoniae and influenza virus. Previously, we demonstrated that several replication-incompetent influenza viruses efficiently elicit IgG in serum and IgA in the upper and lower respiratory tracts. Here, we generated a replication-incompetent hemagglutinin knockout (HA-KO) influenza virus possessing the sequence for the antigenic region of pneumococcal surface protein A (PspA). Although this virus (HA-KO/PspA virus) could replicate only in an HA-expressing cell line, it infected wild-type cells and expressed both viral proteins and PspA. PspA- and influenza virus-specific antibodies were detected in nasal wash and bronchoalveolar lavage fluids and in sera from mice intranasally inoculated with HA-KO/PspA virus, and mice inoculated with HA-KO/PspA virus were completely protected from lethal challenge with either S. pneumoniae or influenza virus. Further, bacterial colonization of the nasopharynx was prevented in mice immunized with HA-KO/PspA virus. These results indicate that HA-KO/PspA virus is a promising bivalent vaccine candidate that simultaneously confers protective immunity against both S. pneumoniae and influenza virus. We believe that this strategy offers a platform for the development of bivalent vaccines, based on replication-incompetent influenza virus, against pathogens that cause respiratory infectious diseases. Streptococcus pneumoniae and influenza viruses cause contagious diseases, but no single vaccine can simultaneously provide protective immunity against both pathogens. Here, we used reverse genetics to generate a replication-incompetent influenza virus carrying the sequence for the antigenic region of pneumococcal surface protein A and demonstrated that mice immunized with this virus were completely protected from lethal doses of infection with either influenza virus or Streptococcus pneumoniae. We believe that this strategy, which is based on a replication-incompetent influenza virus possessing the antigenic region of other respiratory pathogens, offers a platform for the development of bivalent vaccines.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

N9389
4-Nitrophenyl phosphate disodium salt hexahydrate, tablet
C6H4NNa2O6P · 6H2O
N2765
4-Nitrophenyl phosphate disodium salt hexahydrate, tablet
C6H4NNa2O6P · 6H2O
N2640
4-Nitrophenyl phosphate disodium salt hexahydrate, tablet
C6H4NNa2O6P · 6H2O
N4645
4-Nitrophenyl phosphate disodium salt hexahydrate, powder, BioReagent, suitable for cell culture, ≥97%
C6H4NNa2O6P · 6H2O
71768
4-Nitrophenyl phosphate disodium salt hexahydrate, for enzyme immunoassay, ≥99.0% (enzymatic)
C6H4NNa2O6P · 6H2O
A1293 Anti-Mouse IgG (Fab specific)–Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A2179 Anti-Mouse IgG (Fab specific)–Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A1682 Anti-Mouse IgG (Fab specific)–Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB3701030 Anti-Mouse IgG (Fc specific), F(ab′)2 fragment, highly cross adsorbed-Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A1418 Anti-Mouse IgG (Fc specific)–Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A2429 Anti-Mouse IgG (Fc specific)–Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A7434
Anti-Mouse IgG (Fc specific)–Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous glycerol solution
A3438 Anti-Mouse IgG (γ-chain specific)−Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous glycerol solution
A1047 Anti-Mouse IgG (γ-chain specific)−Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB3701133 Anti-Mouse IgG (H+L), F(ab′)2 fragment-Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A5153 Anti-Mouse IgG (whole molecule)−Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A3688 Anti-Mouse IgG (whole molecule)−Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous glycerol solution
A4656 Anti-Mouse IgG (whole molecule)−Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
A9316 Anti-Mouse IgG (whole molecule)−Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous glycerol solution
SAB3701016 Anti-Mouse IgG F(ab′)2, F(ab′)2 fragment, highly cross absorbed-Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB3700994 Anti-Mouse IgG F(ab′)2-Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous solution
P4744
Phosphatase substrate, powder
C6H4NNa2O6P · 6H2O
S0942
Phosphatase substrate, 5 mg tablets
C6H4NNa2O6P · 6H2O
P5994
Phosphatase substrate, 40 mg tablets
C6H4NNa2O6P · 6H2O
P5744
Phosphatase substrate, 40 mg capsules
C6H4NNa2O6P · 6H2O
P5869
Phosphatase substrate, 100 mg capsules
C6H4NNa2O6P · 6H2O
SRE0026
Phosphatase substrate, Suitable for manufacturing of diagnostic kits and reagents
C6H4NNa2O6P · 6H2O
P7255
Puromycin dihydrochloride from Streptomyces alboniger, ≥98% (HPLC), powder
C22H29N7O5 · 2HCl
P8833
Puromycin dihydrochloride from Streptomyces alboniger, powder, BioReagent, suitable for cell culture
C22H29N7O5 · 2HCl